Opus Genetics, Inc. earnings per share and revenue

IRD earnings per share for the last quarter are -1.27 USD whereas the estimation was -0.24 USD which accounts for -418.37% surprise. Company revenue for the same period amounts to 4.30 M USD despite the estimated figure of 3.40 M USD. Estimated earnings per share for the next quarter are -0.28 USD, and revenue is expected to reach 3.40 M USD. Also watch annual changes over time to get a bigger picture of IRD earnings per share and revenue dynamics.